Evidence map›Paper›PMID 41248810›Full record

ArticleNeurobiology of disease2025

Cortical beta power modulation is asymmetric and reduced during movement execution and inhibition in Parkinson's disease.

Roohollah J Deligani, Enrico Opri, Benjamin B Risk, Felicia Goldstein, Stewart A Factor, Lenora A Higginbotham, Nicole C Swann, Svjetlana Miocinovic

Abstract read
In one paragraph

Article in Neurobiology of disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Roohollah J DeliganiDepartment of Neurology, Emory University School of Medicine, Atlanta, GA, USA.
Enrico OpriDepartment of Biomedical Engineering, University of Michigan, Ann Arbor, MI, USA.
Benjamin B RiskDepartment of Biostatistics and Bioinformatics, Emory University, Atlanta, GA, USA.
Felicia GoldsteinDepartment of Neurology, Emory University School of Medicine, Atlanta, GA, USA.
Stewart A FactorDepartment of Neurology, Emory University School of Medicine, Atlanta, GA, USA.
Lenora A HigginbothamDepartment of Neurology, Emory University School of Medicine, Atlanta, GA, USA.
Nicole C SwannDepartment of Human Physiology, University of Oregon, Eugene, OR, USA.
Svjetlana MiocinovicDepartment of Neurology, Emory University School of Medicine, Atlanta, GA, USA. Electronic address: svjetlana.miocinovic@emory.edu.

Funding

Research Services CoreP50NS123103 · NINDS · EMORY UNIVERSITY · PI WICHMANN, THOMAS · 2021 to 2025
$11.7M
NINDS NIH HHS P50 NS123103
6 · The paper itself

Abstract

Inability to initiate movements is a cardinal feature of Parkinson's disease (PD), but inhibitory motor control is also impaired. Cortical electrophysiologic spectral patterns of these processes are still poorly understood. We investigated cortical electrophysiology during movement planning, execution and proactive inhibition in patients with PD. We hypothesized that in the healthy state, proactive inhibition is accompanied by increased beta band activity in the right frontal cortex, and that this process is impaired in PD patients. We recorded 64-channel EEG in 20 moderately advanced PD patients, off and on levodopa, and 20 age-matched healthy controls during cued Go and Go/NoGo tasks and performed spectral time-frequency analysis. PD patients exhibited prolonged response times, more errors and altered cortical activity patterns compared to controls. Levodopa improved movement execution in a simple Go task, but impaired proactive inhibition in a more complex Go/NoGo task. Spectral EEG analysis during movement planning and execution (Go task) showed reduced beta power modulation in PD patients particularly in the more impaired hemisphere, off and on levodopa. When proactive inhibition was engaged (Go/NoGo task), beta power over the right lateral frontal cortex was higher (i.e. decreased less compared to Go task) in healthy controls than in PD patients on medications. In conclusion, PD patients exhibit decreased and asymmetric beta power modulation over the sensorimotor cortex during movement. Proactive inhibition is associated with elevated beta activity over the right lateral frontal cortex in healthy controls, and this pattern is attenuated in PD patients in conjunction with a behavioral inhibitory deficit.

Indexed as

Beta RhythmCerebral CortexInhibition, PsychologicalParkinson DiseaseAgedAntiparkinson AgentsElectroencephalographyFemaleHumansLevodopaMaleMiddle AgedMovementPsychomotor PerformanceReaction TimeAntiparkinson AgentsLevodopaGo/no-go taskImpulsivityLateralizationProactive inhibitionResponse inhibition

Identifiers

PMID41248810
PMCPMC12715724

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.